149 related articles for article (PubMed ID: 11588033)
1. Alterations of the phosphoinositide 3-kinase and mitogen-activated protein kinase signaling pathways in the erythropoietin-independent Spi-1/PU.1 transgenic proerythroblasts.
Barnache S; Mayeux P; Payrastre B; Moreau-Gachelin F
Blood; 2001 Oct; 98(8):2372-81. PubMed ID: 11588033
[TBL] [Abstract][Full Text] [Related]
2. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
[TBL] [Abstract][Full Text] [Related]
3. Growth factor-independent proliferation of erythroid cells infected with Friend spleen focus-forming virus is protein kinase C dependent but does not require Ras-GTP.
Muszynski KW; Thompson D; Hanson C; Lyons R; Spadaccini A; Ruscetti SK
J Virol; 2000 Sep; 74(18):8444-51. PubMed ID: 10954544
[TBL] [Abstract][Full Text] [Related]
4. Gab1 transduces PI3K-mediated erythropoietin signals to the Erk pathway and regulates erythropoietin-dependent proliferation and survival of erythroid cells.
Fukumoto T; Kubota Y; Kitanaka A; Yamaoka G; Ohara-Waki F; Imataki O; Ohnishi H; Ishida T; Tanaka T
Cell Signal; 2009 Dec; 21(12):1775-83. PubMed ID: 19665053
[TBL] [Abstract][Full Text] [Related]
5. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
6. Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors.
Zhang J; Lodish HF
Blood; 2004 Sep; 104(6):1679-87. PubMed ID: 15166036
[TBL] [Abstract][Full Text] [Related]
7. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
[TBL] [Abstract][Full Text] [Related]
8. Erythroid cells rendered erythropoietin independent by infection with Friend spleen focus-forming virus show constitutive activation of phosphatidylinositol 3-kinase and Akt kinase: involvement of insulin receptor substrate-related adapter proteins.
Nishigaki K; Hanson C; Ohashi T; Thompson D; Muszynski K; Ruscetti S
J Virol; 2000 Apr; 74(7):3037-45. PubMed ID: 10708418
[TBL] [Abstract][Full Text] [Related]
9. The SH2 inositol 5-phosphatase Ship1 is recruited in an SH2-dependent manner to the erythropoietin receptor.
Mason JM; Beattie BK; Liu Q; Dumont DJ; Barber DL
J Biol Chem; 2000 Feb; 275(6):4398-406. PubMed ID: 10660611
[TBL] [Abstract][Full Text] [Related]
10. Co-operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factor.
Arcasoy MO; Jiang X
Br J Haematol; 2005 Jul; 130(1):121-9. PubMed ID: 15982354
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
Halevy O; Cantley LC
Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
[TBL] [Abstract][Full Text] [Related]
12. Spi-1 transgenic mice develop a clonal erythroleukemia which does not depend on p53 mutation.
Barnache S; Wendling F; Lacombe C; Denis N; Titeux M; Vainchenker W; Moreau-Gachelin F
Oncogene; 1998 Jun; 16(23):2989-95. PubMed ID: 9662331
[TBL] [Abstract][Full Text] [Related]
13. A minimal cytoplasmic subdomain of the erythropoietin receptor mediates p70 S6 kinase phosphorylation.
Zhang MY; Barber DL; Alessi DR; Bell LL; Stine C; Nguyen MH; Beattie BK; Cheung JY; Miller BA
Exp Hematol; 2001 Apr; 29(4):432-40. PubMed ID: 11301183
[TBL] [Abstract][Full Text] [Related]
14. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia.
Zochodne B; Truong AH; Stetler K; Higgins RR; Howard J; Dumont D; Berger SA; Ben-David Y
Oncogene; 2000 May; 19(19):2296-304. PubMed ID: 10822380
[TBL] [Abstract][Full Text] [Related]
15. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor.
Miura Y; Miura O; Ihle JN; Aoki N
J Biol Chem; 1994 Nov; 269(47):29962-9. PubMed ID: 7961995
[TBL] [Abstract][Full Text] [Related]
16. The signal transduction pathway of erythropoietin involves three forms of mitogen-activated protein (MAP) kinase in UT7 erythroleukemia cells.
Gobert S; Duprez V; Lacombe C; Gisselbrecht S; Mayeux P
Eur J Biochem; 1995 Nov; 234(1):75-83. PubMed ID: 8529671
[TBL] [Abstract][Full Text] [Related]
17. Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cells.
Ammarguellat F; Llovera M; Kelly PA; Goffin V
Biochem Biophys Res Commun; 2001 Jun; 284(4):1031-8. PubMed ID: 11409898
[TBL] [Abstract][Full Text] [Related]
18. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells.
Sakamoto H; Kitamura T; Yoshimura A
J Biol Chem; 2000 Nov; 275(46):35857-62. PubMed ID: 10960479
[TBL] [Abstract][Full Text] [Related]
19. Activation of Raf/ERK1/2 MAP kinase pathway is involved in GM-CSF-induced proliferation and survival but not in erythropoietin-induced differentiation of TF-1 cells.
Kolonics A; Apáti A ; Jánossy J; Brózik A; Gáti R; Schaefer A; Magócsi M
Cell Signal; 2001 Oct; 13(10):743-54. PubMed ID: 11602185
[TBL] [Abstract][Full Text] [Related]
20. Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation.
Rimmelé P; Kosmider O; Mayeux P; Moreau-Gachelin F; Guillouf C
Blood; 2007 Apr; 109(7):3007-14. PubMed ID: 17132716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]